Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Drug resistance is a severe problem in HIV treatment. HIV protease is a common target for the design of new drugs for treating HIV infection. Previous studies have shown that the crystallographic structures of the HIV2 protease (PR2) in bound and unbound forms exhibit structural asymmetry that is important for ligand recognition and binding. |